Chengda Wu

机构：Hubei University of Medicine

发表论文 2 篇 · 总被引 85 次 · h-index 2

代表论文

• Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ETAreceptor antagonist (2000 · Pulmonary Pharmacology & Therapeutics · 被引 75)
• Comparison of the efficacy and safety of different growth factors in the treatment of diabetic foot ulcers: an updated network meta-analysis (2025 · Frontiers in Endocrinology · 被引 10)